Dr. Reiner is Professor and co-founder of the National Core for Neuroethics, and a member of the Department of Psychiatry and the Brain Research Centre. Dr. Reiner began his research career studying the cellular and molecular physiology of the brain, with particular interests in the neurobiology of behavioural states and the molecular underpinnings of neurodegenerative disease. In 1998, Dr. Reiner became President and CEO of Active Pass Pharmaceuticals, a drug discovery company that he founded to tackle the scourge of Alzheimer’s disease. Upon returning to academic life in 2004, Dr. Reiner refocused his scholarly work in the area of neuroethics, co-founding the National Core for Neuroethics with Dr. Judy Illes in 2007. His work in neuroethics focuses upon public attitudes towards cognitive enhancement and the impact of emerging neuroessentialist thought on modern society.